Erick Gamelin - Nov 14, 2023 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Chief Medical Officer
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Nov 14, 2023
Transactions value $
-$7,087
Form type
4
Date filed
11/16/2023, 07:41 PM
Previous filing
Nov 16, 2022
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability -$7.09K -1.4K -6.96% $5.08 18.6K Nov 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.